Aurobindo Pharma Ltd. logo

Aurobindo Pharma Ltd. share price

NSE: AUROPHARMA · Healthcare

₹1,794.00 -1.60%

Closing price data, updated 17 Nov 2026. 52-week range: -3.5% from high, +62.2% above low.

Price₹1,794.00
Market cap₹1,03,223 Cr
P/E25.9
P/B2.62
ROE9.9%
ROCE13.5%
Debt / equity0.21
Dividend yield0.00%
EPS₹69.35
Book value₹684.77
Operating margin15.6%
Dipscan score60 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Aurobindo Pharma Ltd. shareholding pattern

As of Sep 2026: Promoters 51.88%, FIIs 17.41%, DIIs 24.42%, Government 0.00%, Public 5.02%, Others 1.27%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters51.88%51.88%51.82%51.82%51.82%51.82%
FIIs17.41%16.38%15.24%13.94%14.21%14.37%
DIIs24.42%25.10%25.87%27.68%27.60%26.93%
Government0.00%0.00%0.00%0.00%0.00%0.00%
Public5.02%5.36%5.74%5.36%5.25%5.67%
Others1.27%1.28%1.34%1.19%1.13%1.20%
No. of Shareholders233,737239,073241,298236,859247,662272,208

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-1.60%-0.33%+7.88%+7.85%+18.74%+55.35%

Growth

Sales growth, 3 years+10.7%
Sales growth, 5 years–
Profit growth, 3 years+22.1%
Profit growth, 5 years–
Latest quarter sales vs last year–
Latest quarter profit vs last year–

Strengths and weaknesses

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Aurobindo Pharma Ltd.?

Aurobindo Pharma Ltd. (AUROPHARMA) last closed at ₹1,794.00 (-1.60% on the day).

What is the market cap of Aurobindo Pharma Ltd.?

About ₹1,03,223 Cr.

What is the P/E ratio of Aurobindo Pharma Ltd.?

The price-to-earnings ratio is 25.9, and return on equity is 9.9%.

Figures are calculated from company results and exchange prices and are for information only.